Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
Cash BD, Lacy BE, Rao T, Earnest DL. Cash BD, et al. Among authors: earnest dl. Expert Opin Pharmacother. 2016;17(3):311-22. doi: 10.1517/14656566.2016.1118052. Epub 2015 Dec 8. Expert Opin Pharmacother. 2016. PMID: 26559529 Review.
Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.
Olden KW, Chey WD, Shringarpure R, Paul Nicandro J, Chuang E, Earnest DL. Olden KW, et al. Among authors: earnest dl. Curr Med Res Opin. 2019 Mar;35(3):461-472. doi: 10.1080/03007995.2018.1533456. Epub 2018 Nov 22. Curr Med Res Opin. 2019. PMID: 30293448
Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint.
Lacy BE, Nicandro JP, Chuang E, Earnest DL. Lacy BE, et al. Among authors: earnest dl. Therap Adv Gastroenterol. 2018 May 8;11:1756284818771674. doi: 10.1177/1756284818771674. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 29774051 Free PMC article.
Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome.
Tougas G, Snape WJ Jr, Otten MH, Earnest DL, Langaker KE, Pruitt RE, Pecher E, Nault B, Rojavin MA. Tougas G, et al. Among authors: earnest dl. Aliment Pharmacol Ther. 2002 Oct;16(10):1701-8. doi: 10.1046/j.1365-2036.2002.01347.x. Aliment Pharmacol Ther. 2002. PMID: 12269961 Clinical Trial.
Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study.
Loughlin J, Quinn S, Rivero E, Wong J, Huang J, Kralstein J, Earnest DL, Seeger JD. Loughlin J, et al. Among authors: earnest dl. J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):151-7. doi: 10.1177/1074248409360357. Epub 2010 Mar 3. J Cardiovasc Pharmacol Ther. 2010. PMID: 20200325
Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation.
Müller-Lissner S, Kamm MA, Musoglu A, Earnest DL, Dunger-Baldauf C, Shetzline MA. Müller-Lissner S, et al. Among authors: earnest dl. Am J Gastroenterol. 2006 Nov;101(11):2558-69; quiz 2671. doi: 10.1111/j.1572-0241.2006.00789.x. Am J Gastroenterol. 2006. PMID: 17090282 Clinical Trial.
Omeprazole-induced slowing of gastrointestinal transit in mice can be countered with tegaserod.
Cowan A, Earnest DL, Ligozio G, Rojavin MA. Cowan A, et al. Among authors: earnest dl. Eur J Pharmacol. 2005 Jul 4;517(1-2):127-31. doi: 10.1016/j.ejphar.2005.05.041. Eur J Pharmacol. 2005. PMID: 15972210
Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.
Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M. Vakil N, et al. Among authors: earnest dl. Am J Gastroenterol. 2008 Aug;103(8):1906-19. doi: 10.1111/j.1572-0241.2008.01953.x. Epub 2008 Jul 4. Am J Gastroenterol. 2008. PMID: 18616658 Free article. Clinical Trial.
Long-term tegaserod treatment for dysmotility-like functional dyspepsia: results of two identical 1-year cohort studies.
Chey WD, Howden CW, Tack J, Ligozio G, Earnest DL. Chey WD, et al. Among authors: earnest dl. Dig Dis Sci. 2010 Mar;55(3):684-97. doi: 10.1007/s10620-009-1049-0. Epub 2009 Dec 3. Dig Dis Sci. 2010. PMID: 19957035 Clinical Trial.
Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.
Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Talley NJ, et al. Among authors: earnest dl. Aliment Pharmacol Ther. 2006 Sep 1;24(5):859-67. doi: 10.1111/j.1365-2036.2006.03049.x. Aliment Pharmacol Ther. 2006. PMID: 16918891 Clinical Trial.
101 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback